Automata
WashedAI NativePrivateUpdated November 15, 2026A legacy robotics and RPA vendor rebranding as AI automation without the underlying investment.
- Website
- automata.tech
- Founded
- 2015
- CEO
- Mostafa ElSayed
- HQ
- London, United Kingdom
- Stage
- Private
- Revenue
- Not disclosed
- Total Funding
- $177M
- Employees
- 11-50
Executive Summary
Updated Nov 12, 2026
What they do
- Builds LINQ, a modular robotic lab bench plus orchestration software
- Automates end-to-end wet-lab workflows for pharma, biotech and research labs
- Connects lab hardware and data to AI models, including via MCP
Why it matters
- Reports five top-pharma customers with repeat deployments driving growth
- $45M Series C in 2026 led by Dimension, with Danaher Ventures
- Beckman Coulter and CellVoyant partnerships push toward closed-loop, AI-guided experimentation
Best fit
- Pharma and biotech R&D labs scaling high-throughput or cell-based workflows
- CROs wanting walkaway automation across multi-instrument, end-to-end processes
- Teams building AI-driven discovery that needs programmable, data-connected wet labs
Watch-outs
- Hardware-heavy deployments mean significant capex, lab space and integration effort
- Danaher ties may favour Beckman instruments over other vendors' ecosystems
- Closed-loop AI experimentation features are new and lightly proven at scale
Products & Offerings
LINQ Platform
Integrated lab automation platform that combines modular robotic benches with orchestration software and AI-ready data architecture.
LINQ Cloud
Cloud software for designing, testing, scheduling and managing automated lab workflows remotely across connected workcells.
LINQ Bench
Lab-bench-sized modular hardware system with integrated robotics and labware transport that hosts third-party instruments.
LINQ Canvas
No-code, node-based workflow builder for creating and changing automated lab protocols.
LINQ Run Manager
Run-management software for parallel workflow execution, live monitoring and real-time error handling.
Updated Nov 12, 2026
Automata is a credible, well-funded specialist in integrated lab automation, with top-pharma customers and strategic backing from Danaher. Pharma, biotech and CRO buyers modernising wet-lab workflows should run a structured evaluation against Biosero, HighRes Biosolutions and the big instrument makers' automation offerings. Test claims of instrument openness and of AI or closed-loop capability on your own workflows. It is not a general enterprise AI platform and suits only life-sciences lab use cases.
Signal Provenance
Latest observation date and source for each signal category
| Signal Category | Last Updated | Source |
|---|---|---|
Funding Signals Last funding round, Funding stage | Nov 15, 2026 | Cited web research |
Hiring Velocity Headcount, Headcount growth | Nov 9, 2026 | Research agents (estimate) |
Technical Output Research papers, GitHub activity | Nov 15, 2026 | Hugging Face Hub + news feed + research agents |
News Sentiment News mentions, News sentiment | Nov 15, 2026 | Verified news feed |
Partnership Signals Enterprise partnerships, Distribution partners | Nov 12, 2026 | Research agents (estimate) |
Revenue Indicators ARR estimate, Revenue growth | Nov 15, 2026 | Research agents (estimate) |
Leadership Signals CEO tenure, Founder-led | Oct 19, 2026 | Research agents (estimate) |
Competitive Position Category rank, Market share | Never | Research agents (estimate) |
Why this Bluescore?
6 dimensions, each scored 0–10 against all 250 companies. Each adds its weight × score to the Bluescore — see methodology
Automata's Bluescore of 33.9 rests most on Customer Adoption (5.2, 50th percentile). Its weakest area is Product Depth (1.9, 2nd percentile).
In plain English
Automata's Bluescore of 33.9 out of 100 places it at #237 of 247 ranked companies, helped mainly by Business Model & Revenue, which adds 9.2 of 21 points, and Customer Adoption, which adds 6.8 of 13 points. Product Depth is the biggest drag: it scores 1.9 of 10, sits at the 2nd percentile among the AI250, and adds only 3.9 of 21 points with 17.1 left. Because Product Depth carries a 21% weight and has the most points still unclaimed, improving it would likely move the Bluescore more than any other dimension.
Written by AI from the scores below and checked against them; updated nightly.
Risks
Updated Nov 12, 2026